John Haserick

John Haserick

Company: Innovac Therapeutics

Job title: Vice President Of Platform Development


Ensuring Excellence: Quality Control of Raw & Starting Materials for mRNA-Based Therapeutics 11:00 am

What specific attributes of mRNA raw materials are evaluated during quality control processes, and how do these attributes influence the safety and efficacy of the final product?  What are the established regulatory guidelines for quality control of mRNA raw materials?  What strategies are being explored to address challenges related to batch-to-batch variability and quality assurance? Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.